<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cure - Go-to-Market</title>
    <link>https://wewillcure.com/insights/go-to-market</link>
    <description>Latest content from Cure in Go-to-Market</description>
    <language>en</language>
    <lastBuildDate>Wed, 20 May 2026 22:46:30 GMT</lastBuildDate>
    <atom:link href="https://wewillcure.com/insights/go-to-market/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <guid>https://wewillcure.com/insights/innovation-index/translational-research/cure-launches-first-national-index-revealing-what-it-takes-to-turn-science</guid>
      <title><![CDATA[Cure Launches First National Index Revealing What it Takes to Turn Science into Cures ]]></title>
      <link>https://wewillcure.com/insights/innovation-index/translational-research/cure-launches-first-national-index-revealing-what-it-takes-to-turn-science</link>
      <description><![CDATA[Success factors go beyond funding, publications and patents to identify the top 303 U.S. Research Institutions making real-world impact ]]></description>
      <pubDate>Wed, 29 Apr 2026 12:15:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6MxfUi60y5ol0hu4UAbhVD/66b4504694ccb40904f357a7585e1ca8/CII-Launch_innovation_index.png" medium="image" />
      <category>Press Release</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/go-to-market/funding-and-models/trumprx-rewriting-biotech-playbook-heres-how-startups-should-respond</guid>
      <title><![CDATA[TrumpRx Is Rewriting Biotech’s Playbook—Here’s How Startups Should Respond]]></title>
      <link>https://wewillcure.com/insights/go-to-market/funding-and-models/trumprx-rewriting-biotech-playbook-heres-how-startups-should-respond</link>
      <description><![CDATA[TrumpRx and MFN pricing deals are reshaping how biotech startups market medicines, set prices, and plan U.S. manufacturing. Here’s what founders need to know before the 2026 rollout.]]></description>
      <pubDate>Fri, 07 Nov 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/1RSmcUh35DzpzgfrHJ4etu/061957621f186970ed038fba1f0302db/Ozempic_Pills_Drugs_SS2440411479.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/go-to-market/womens-health-gtm-strategies-entrepreneurs</guid>
      <title><![CDATA[4 Women’s Health Entrepreneurs Reveal Go-to-Market Strategies]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/go-to-market/womens-health-gtm-strategies-entrepreneurs</link>
      <description><![CDATA[Founders behind Elektra Health, Frame Fertility, Gabbi, and OOVA share how trial, error and trust shaped their GTM journeys.]]></description>
      <pubDate>Mon, 30 Jun 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3c7D3t7b3q5NsWvplpEZvw/7cc48c63a64707a9c33d9dcba1015cc3/thumbnail_4_Female_founders_mosaic_2x-updated.jpg" medium="image" />
      <category>Article</category>
    </item>
  </channel>
</rss>